Recent advances in Staphylococcus aureus infection: focus on vaccine development

Clicks: 303
ID: 5859
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #619 of 1,693 articles by views in Infection and drug resistance

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,693 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Recent advances in Staphylococcus aureus infection: focus on vaccine development Shamshul Ansari,1 Rajesh Kumar Jha,2 Shyam Kumar Mishra,3 Birendra Raj Tiwari,4 Ahmed Morad Asaad51Department of Microbiology, Chitwan Medical College and Teaching Hospital, Bharatpur, Chitwan, Nepal; 2Department of Systems and Diseases (Pharmacology), Saba University School of Medicine, Saba, Dutch Caribbean; 3Department of Microbiology, Maharajgunj Medical Campus, Institute of Medicine, Tribhuvan University, Kathmandu, Nepal; 4Department of Microbiology, Saint James School of Medicine, Anguilla, BWI; 5Department of Microbiology, Faculty of Medicine, Zagazig University, Zagazig, EgyptAbstract: Staphylococcus aureus normally colonizes the nasal cavity and pharynx. After breaching the normal habitat, the organism is able to cause a number of infections at any site of the body. The development of antibiotic resistance has created a global challenge for treating infections. Therefore, protection by vaccines may provide valuable measures. Currently, several vaccine candidates have been prepared which are either in preclinical phase or in early clinical phase, whereas several candidates have failed to show a protective efficacy in human subjects. Approaches have also been made in the development of monoclonal or polyclonal antibodies for passive immunization to protect from S. aureus infections. Therefore, in this review we have summarized the findings of recently published scientific literature to make a concise report.Keywords: active immunization, passive immunization, Staphylococcus aureus, vaccine
Reference Key
shamshul2019recentinfection Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Shamshul Ansari;Rajesh Kumar Jha;Shyam Kumar Mishra;Birendra Raj Tiwari;Ahmed Morad Asaad and
Journal Infection and drug resistance
Year 2019
DOI
10.2147/IDR.S175014
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.